GC and heart failure: Furthermore, in addition to sildenafil, other cGMP-PKG activating agents are under investigation in heart failure, such as the GC activators cinaciguat and nesiritide.41,42 To date, most clinical trials of these agents have focused on their rapid PKGI-mediated vasodilating effects in the setting of acute decompensated heart failure.